FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

  1. Cervantes, A.
  2. Prager, G.W.
Aldizkaria:
ESMO Open

ISSN: 2059-7029

Argitalpen urtea: 2023

Alea: 8

Zenbakia: 2

Mota: Editoriala

DOI: 10.1016/J.ESMOOP.2023.100883 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus